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Background
Asthma is the most prevalent of all childhood diseases and
accounts for the majority of hospitalizations and school
absences in children [1]. Current mouse model research
has identified the early life gut microbiota as a potential
therapeutic target for the prevention of asthma and atopic
diseases [2-4]. We hypothesize that the early life gut
microbiota could play a similar preventative role against
atopic disease development in humans.
Methods
1262 children enrolled in the Canadian Healthy Infant
Longitudinal Development (CHILD) Study with com-
plete skin prick test and wheeze data at one year were
grouped into four clinically relevant phenotypes: atopy +
wheeze, atopy only, wheeze only, and control. Bacterial
16S rDNA from 3-month and 1-year stool samples of
319 children in these four phenotypes was extracted,
amplified, and subjected to high throughput Illumina
sequencing. Quantitative polymerase chain reaction
(qPCR) and short chain fatty acid (SCFA) analysis were
also conducted on 44 children in the two extreme phe-
notypes (atopy + wheeze vs. control).
Results
16S sequence analysis of our sample cohort (319 subjects)
identified bacterial populations that differed in abundance
in the atopy + wheeze group at 3-months of age but not
at 1-year of age. Additionally, significant changes in the
abundance of certain bacterial genera were found in the
atopy + wheeze group when compared to controls by
qPCR at 3-months of age only. Changes in stool short
chain fatty acid production between the atopy + wheeze
group and the control group were also observed at 3-
months of age only.
Conclusions
Shifts in the relative abundance of certain gut bacterial
populations and differences in the levels of stool SCFAs
before 3-months of age are associated with atopy and
wheeze at one year of age.
Authors’ details
1Department of Microbiology & Immunology, University of British Columbia,
Vancouver, British Columbia, V6T 1Z4, Canada. 2The Child and Family
Research Institute, Vancouver, British Columbia, V4Z 4H4, Canada. 3Michael
Smith Laboratories, University of British Columbia, Vancouver, British
Columbia, V6T 1Z4, Canada. 4Department of Statistics, University of British
Columbia, Vancouver, British Columbia, V6T 1Z4, Canada. 5St. Joseph’s
Healthcare, Hamilton, Ontario, L8N 4A6, Canada. 6Department of Medicine,
McMaster University, Hamilton, Ontario, L8S 4L8, Canada. 7Department of
Pediatrics, University of Toronto, Toronto, Ontario, M5S 2J7, Canada.
8Hospital for Sick Children, Toronto, Ontario, M5G 1X8, Canada. 9Department
of Pediatrics, University of Alberta, Edmonton, Alberta, T6G 2R3, Canada.
10School of Public Health, University of Alberta, Edmonton, Alberta, T6G 2R3,
Canada. 11Department of Pediatrics and Child Health, University of Manitoba,
Winnipeg, Manitoba, R3T 2N2, Canada. 12Department of Pediatrics, University
of British Columbia, Vancouver, British Columbia, V6T 1Z4, Canada.
13Department of Biochemistry and Molecular Biology, University of British
Columbia, Vancouver, British Columbia, V6T 1Z4, Canada.
Published: 18 December 2014
References
1. Asthma. World Health Organization; 2011.
2. Zeng B, Li G, Yuan J, Li W, Tang H, Wei H: Effects of age and strain on the
microbiota colonization in an infant human flora-associated mouse
model. Current Microbiology 2013, 67:313-21.
3. Russell SL, Gold MJ, Willing BP, Thorson L, McNagny KM, Finlay BB: Perinatal
antibiotic treatment affects murine microbiota, immune responses and
allergic asthma. Gut Microbes 2013, 4:158-64.
* Correspondence: lthomas@cfri.ca
† Contributed equally
1Department of Microbiology & Immunology, University of British Columbia,
Vancouver, British Columbia, V6T 1Z4, Canada
Full list of author information is available at the end of the article
Stiemsma et al. Allergy, Asthma and Clinical Immunology 2014, 10(Suppl 2):A63
http://www.aacijournal.com/content/10/S2/A63 ALLERGY, ASTHMA & CLINICAL 
IMMUNOLOGY
© 2014 Stiemsma et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
4. Arnold IC, Dehzad N, Reuter S, Martin H, Becher B, Taube C, Muller A:
Helicobacter pylori infection prevents allergic asthma in mouse models
through the induction of regulatory T cells. The Journal of Clinical
Investigation 2011, 121:3088-3093.
doi:10.1186/1710-1492-10-S2-A63
Cite this article as: Stiemsma et al.: The early life gut microbiota and
atopic disease. Allergy, Asthma and Clinical Immunology 2014 10(Suppl 2):
A63.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Stiemsma et al. Allergy, Asthma and Clinical Immunology 2014, 10(Suppl 2):A63
http://www.aacijournal.com/content/10/S2/A63
Page 2 of 2
